Pfizer’s (PFE) $11B Share Repurchase Plan Deflates AstraZeneca Bid Hopes

U.S. drugmaker Pfizer (PFE) announced a new share repurchase program of up to $11 billion of its common stock Thursday night, deflating expectations that it will make a new bid for AstraZeneca. The New York-based pharmaceuticals company, whose shares gained nearly 2% after the announcement, said the move was in addition to the $1.3 billion […] View the full post at: Pfizer’s (PFE) $11B Share Repurchase Plan Deflates AstraZeneca Bid Hopes Related posts: Fidelity Asked By Regulator To Repurchase Auction Rate Securities Microsoft, Hewlett-Packard Increase Stock Buybacks Treasury Sends Congress Unprecedented $700 billion Bailout Plan